OncoCyte Corporation (NASDAQ:OCX) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Tamika and I will be your conference operator today.
Stay updated with breaking news from Mark Massaro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Thank you for standing by. My name is Tamika and I will be your conference operator today.
Operator: Hello, everyone, and welcome to the Guardant Health Q3 2023 Earnings Call. My name is Thrisha, and I'll be your operator today.
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
EXAS earnings call for the period ending September 30, 2023.
In the world of stock markets, a well-known adage prevails: insiders may sell shares of their own companies for a myriad of reasons, but their decision to buy stock typically hinges on one belief – that the shares are set to rise. By insiders, we mean the corporate officers that sit on company boards and are the in-the-know types with access to the sort of information not available to the casual investor. By law, they are required to make their purchases public, thereby keeping the playing field